ERLOTINIB HYDROCHLORIDE
NDC 62332-565, ERLOTINIB HYDROCHLORIDE, tablet, film coated, from Alembic Pharmaceuticals Inc..
- Product NDC
- 62332-565
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214719
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62332-565 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERLOTINIB HYDROCHLORIDE25 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62332-565-30 | 62332056530 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-565-30) |
| 62332-565-90 | 62332056590 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-565-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ccf1e415-4980-462f-8ac2-87979bda149e
Use it
Look up 62332-565 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62332-565 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62332-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.